Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

Our study shows good prognostic performance of CRP and IL6 for 28-day hospitalization in patients with mild-to-moderate COVID-19, in the absence of clinical criteria for admission upon enrolment. These findings confirm the value of these biomarkers at early stages of COVID-19 disease in the outpatient setting to support management decisions.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-11-27
DOI
https://doi.org/10.3389/fimmu.2024.1501872
Citations
1
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

Bàrbara Baró, Pere Millat-Martínez, Cristian Morales‐Indiano, Gemma Moncunill et al.
1 citations
Frontiers in Immunology
COVID-19 Clinical Research Studies
0.39
article

Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

Bàrbara Baró, Pere Millat-Martínez, Cristian Morales‐Indiano, Gemma Moncunill, Núria Balanza, Ruth Aguilar, Andrea Alemany, Marc Corbacho‐Monné, Ignacio Blanco, Dan Ouchi, Gema Fernández Rivas, Quique Bassat, Carlota Dobaño, Oriol Mitjà
article en
1 citations

Abstract

Our study shows good prognostic performance of CRP and IL6 for 28-day hospitalization in patients with mild-to-moderate COVID-19, in the absence of clinical criteria for admission upon enrolment. These findings confirm the value of these biomarkers at early stages of COVID-19 disease in the outpatient setting to support management decisions.

Frontiers in ImmunologyVol. 15
Institució Catalana de Recerca i Estudis Avançats (ES), Hospital Sant Joan de Déu Barcelona (ES), Instituto de Salud Carlos III (ES), Departament de Salut (ES), Centro de Investigación Biomédica en Red (ES), Manhiça Health Research Centre (MZ), Transports Metropolitans de Barcelona (Spain) (ES), Barcelona Institute for Global Health (ES), Hospital Universitari Germans Trias i Pujol (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Fundació Lluita contra les Infeccions (ES), Deleted Institution, Universitat de Barcelona (ES)
Reduced inequalities
Openalex Percentile: Top 34%
COVID-19 Clinical Research Studies
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.